Comparing between Hydroxyurea and Non-Hydroxyurea Anti-inflammatory Cytokines in Sickle Cell Anemia Saudi Patients

被引:0
|
作者
Tarbiah, Nesrin, I [1 ]
Alamri, Reema S. [1 ]
Alkhattabi, Nuha A. [1 ]
Alhemadi, Maryam M. [1 ]
Almutairi, Huda S. [1 ]
Alzahri, Reem Y. [2 ]
Hussain, Hend [3 ]
机构
[1] King Abdulaziz Univ, Dept Biochem, Jeddah, Saudi Arabia
[2] Jeddah Univ, Dept Biol, Jeddah, Saudi Arabia
[3] King Abdulaziz Univ, Dept Hematol, Jeddah, Saudi Arabia
关键词
Anti-inflammatory cytokines; Hydroxyurea; Inflammation; Sickle cell disease; DISEASE PATIENTS; IL-37;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Sickle Cell Anemia (SCA) is a hemolytic deficiency that is typified by strangely formed (sickles) red blood cells that are expelled from circulation at expanded rates, leading to anemia. It is caused by inheritance of hemoglobin (Hb) that has mutated, which compared to adult normal Hb, contains a single amino acid substitution, where at the sixth residue valine substitutes glutamic acid in the Hb tetramer in both of the two B chains. For SCA patients, chronic inflammatory conditions are linked to high levels of inflammation markers, including cytokines and adhesion molecules. Cytokines are a group of small proteins that are essential in cell signaling. The immuno regulatory molecules known as anti-inflammatory cytokines control the response of pro inflammatory and have gained attention recently as anti-inflammatory mediator in SCA patients. The most interesting anti-inflammatory cytokines are IL-10, IL-4, IL-27, and IL-37. This a case-control study aimed to measure the concentrations of the anti-inflammatory cytokines in 3 groups, SCA patients without the use of any medication, SCA patients under Hydroxy Urea therapy (SCAHU), and healthy people (male and female) in the general Saudi population, using a total of 78 chosen subjects. Using ELISA kits, cytokine levels were measured in the plasma of the patients. The results of the study indicated that anti-inflammatory cytokines were elevated in SCA and SCAHU patients when compared to the control (P=0.001), and there were no significant differences between SCA and SCAHU patients. The anti-inflammatory cytokines, including IL-27 and IL-37, that were detected for the first time in SCA patients in KSA in this research, have a role in keeping patients in a steady-state and reducing inflammation, therefore more research to understand the roles of these cytokines in SCA pathology of is essential to allow the development of effective therapies to treat this disease.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 50 条
  • [21] Hydroxyurea therapy in sickle cell anemia patients in Curacao, The Netherlands Antilles
    Saleh, AW
    Velvis, HJR
    Gu, LH
    Hillen, HFP
    Huisman, THJ
    ACTA HAEMATOLOGICA, 1997, 98 (03) : 125 - 129
  • [22] Oxidative stress assessment in sickle cell anemia patients treated with hydroxyurea
    Cristiane O. Renó
    Amanda Rodrigues Barbosa
    Sara Santos de Carvalho
    Melina B. Pinheiro
    Danyelle Romana Rios
    Vanessa F. Cortes
    Leandro A. Barbosa
    Hérica L. Santos
    Annals of Hematology, 2020, 99 : 937 - 945
  • [23] Hydroxyurea treatment in patients affected with sickle cell anemia: Efficacy and safety
    de Montalembert, M.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2008, 15 (1-2) : 34 - 38
  • [24] EARLY DETECTION OF RESPONSE TO HYDROXYUREA THERAPY IN PATIENTS WITH SICKLE CELL ANEMIA
    Ballas, Samir K.
    McCarthy, William F.
    Guo, Nan
    Brugnara, Carlo
    Kling, Gail
    Bauserman, Robert L.
    Waclawiw, Myron A.
    HEMOGLOBIN, 2010, 34 (05) : 424 - 429
  • [25] Anti-inflammatory cytokines in sickle cell disease
    Alagbe, Adekunle E.
    Domingos, Igor F.
    Adekile, Adekunle D.
    Blotta, Maria H. S. L.
    Santos, Magnun N. N.
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (03) : 2433 - 2442
  • [26] Anti-inflammatory cytokines in sickle cell disease
    Adekunle E. Alagbe
    Igor F. Domingos
    Adekunle D. Adekile
    Maria H. S. L. Blotta
    Magnun N. N. Santos
    Molecular Biology Reports, 2022, 49 : 2433 - 2442
  • [27] Hydroxyurea alters circulating monocyte subsets and dampens its inflammatory potential in sickle cell anemia patients
    Guarda, Caroline C.
    Silveira-Mattos, Paulo S. M.
    Yahouedehou, Setondji C. M. A.
    Santiago, Rayra P.
    Aleluia, Milena M.
    Figueiredo, Camylla V. B.
    Fiuza, Luciana M.
    Carvalho, Suellen P.
    Oliveira, Rodrigo M.
    Nascimento, Valma M. L.
    Luz, Nivea F.
    Borges, Valeria M.
    Andrade, Bruno B.
    Goncalves, Marilda S.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [28] Hydroxyurea alters circulating monocyte subsets and dampens its inflammatory potential in sickle cell anemia patients
    Caroline C. Guarda
    Paulo S. M. Silveira-Mattos
    Sètondji C. M. A. Yahouédéhou
    Rayra P. Santiago
    Milena M. Aleluia
    Camylla V. B. Figueiredo
    Luciana M. Fiuza
    Suellen P. Carvalho
    Rodrigo M. Oliveira
    Valma M. L. Nascimento
    Nívea F. Luz
    Valéria M. Borges
    Bruno B. Andrade
    Marilda S. Gonçalves
    Scientific Reports, 9
  • [29] Response to hydroxyurea in sickle cell patients with the Saudi Arabia/India haplotype.
    Adekile, A
    BLOOD, 1999, 94 (10) : 416A - 416A
  • [30] Use of hydroxyurea in patients with sickle cell anemia on chronic transfusions for stroke.
    Nadvi, SZ
    Panchoosingh, H
    Thomas, R
    Sarnaik, S
    BLOOD, 1998, 92 (10) : 32B - 32B